Cargando…
Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
We investigated the effect of galectin-3 (Gal-3) inhibition with modified citrus pectin on markers of collagen metabolism in a proof-of-concept randomized placebo-controlled trial of participants with elevated Gal-3 levels and hypertension. Although higher Gal-3 levels were associated with female se...
Autores principales: | Lau, Emily S., Liu, Elizabeth, Paniagua, Samantha M., Sarma, Amy A., Zampierollo, Giovanna, López, Begoña, Díez, Javier, Wang, Thomas J., Ho, Jennifer E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838053/ https://www.ncbi.nlm.nih.gov/pubmed/33532663 http://dx.doi.org/10.1016/j.jacbts.2020.10.006 |
Ejemplares similares
-
Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
por: Kolatsi-Joannou, Maria, et al.
Publicado: (2011) -
Purification, chemical analysis and inhibitory effects on galectin-3 of enzymatic pH-modified citrus pectin
por: Zhang, Tao, et al.
Publicado: (2021) -
Pleiotropic Effects of Modified Citrus Pectin
por: Eliaz, Isaac, et al.
Publicado: (2019) -
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice
por: Lu, Yonggang, et al.
Publicado: (2017) -
Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in
Prostate Cancer
por: Conti, Sefora, et al.
Publicado: (2018)